Major shareholder announcement

Company announcement     No. 10/2023      Orphazyme A/S   Ole Maaløes Vej 3 DK-2200 Copenhagen N         www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, May 19 , 2023 –Orphazyme A/S (ORPHA.CO) (the “Company”), hereby announces the receipt of notification pursuant to Section 38 of the Danish Capital Markets Act from Scandinavian Investment Group A/S, that as of May 16, 2023, Scandinavian Investment Group A/S holds shares corresponding to 10...

Company announcement    

No. 10/2023     

Orphazyme A/S 
Ole Maaløes Vej 3
DK-2200 Copenhagen N        

www.orphazyme.com
Company Registration No. 32266355

Copenhagen, Denmark, May 19, 2023 – Orphazyme A/S (ORPHA.CO) (the “Company”), hereby announces the receipt of notification pursuant to Section 38 of the Danish Capital Markets Act from Scandinavian Investment Group A/S, that as of May 16, 2023, Scandinavian Investment Group A/S holds shares corresponding to 10.00% of the total share capital and voting rights in the Company.

For additional information, please contact

Orphazyme A/S

Michael Hove, Chairman of the board +45 28 12 66 09

Attachment

• Orphazyme - Company announcement - Major shareholder announcement